Market Watch Highlights: TG Therapeutics Inc (TGTX) Ends on an Downturn Note at 35.11

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

As of close of business last night, TG Therapeutics Inc’s stock clocked out at $35.11, down -1.43% from its previous closing price of $35.62. In other words, the price has decreased by -$1.43 from its previous closing price. On the day, 2.41 million shares were traded.

Ratios:

To gain a deeper understanding of TGTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.03 and its Current Ratio is at 6.25. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 1.14.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.

On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 03 ’25 when Power Sean A sold 11,337 shares for $30.29 per share. The transaction valued at 343,443 led to the insider holds 670,632 shares of the business.

Power Sean A sold 10,021 shares of TGTX for $285,939 on Jan 06 ’25. The CFO now owns 660,611 shares after completing the transaction at $28.53 per share. On Jan 06 ’25, another insider, Power Sean A, who serves as the Officer of the company, bought 10,021 shares for $28.53 each.

Valuation Measures:

As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 251.50, and their Forward P/E ratio for the next fiscal year is 18.16. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.76 while its Price-to-Book (P/B) ratio in mrq is 24.61.

Stock Price History:

Over the past 52 weeks, TGTX has reached a high of $36.94, while it has fallen to a 52-week low of $12.93. The 50-Day Moving Average of the stock is 12.93%, while the 200-Day Moving Average is calculated to be 39.31%.

Shares Statistics:

A total of 155.84M shares are outstanding, with a floating share count of 141.36M. Insiders hold about 10.00% of the company’s shares, while institutions hold 62.33% stake in the company.

Most Popular